Attitudes and Approaches for Withdrawing Drugs for Children with Clinically Inactive Nonsystemic JIA: A Survey of the Childhood Arthritis and Rheumatology Research Alliance.

about

Attitudes and Approaches for Withdrawing Drugs for Children with Clinically Inactive Nonsystemic JIA: A Survey of the Childhood Arthritis and Rheumatology Research Alliance.

Item

http://www.wikidata.org/entity/Q36266841

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Attitudes and Approaches for W ...... heumatology Research Alliance.

@ast

Attitudes and Approaches for W ...... heumatology Research Alliance.

@en

type

Item

label

Attitudes and Approaches for W ...... heumatology Research Alliance.

@ast

Attitudes and Approaches for W ...... heumatology Research Alliance.

@en

prefLabel

Attitudes and Approaches for W ...... heumatology Research Alliance.

@ast

Attitudes and Approaches for W ...... heumatology Research Alliance.

@en

P1476

Attitudes and Approaches for W ...... heumatology Research Alliance.

@en

P2093

Sarah Ringold

http://www.w3.org/2001/XMLSchema#string

Timothy Beukelman

http://www.w3.org/2001/XMLSchema#string

P2860

EULAR-PReS points to consider for the use of imaging in the diagnosis and management of juvenile idiopathic arthritis in clinical practice

Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support

Trial of early aggressive therapy in polyarticular juvenile idiopathic arthritis.

Disease-modifying antirheumatic drug use in the treatment of juvenile idiopathic arthritis: a cross-sectional analysis of the CARRA Registry.

Clinical remission in juvenile idiopathic arthritis after termination of etanercept.

Treatment prescribing patterns in patients with juvenile idiopathic arthritis (JIA): Analysis from the UK Childhood Arthritis Prospective Study (CAPS).

Clinical outcomes after withdrawal of anti-tumor necrosis factor α therapy in patients with juvenile idiopathic arthritis: a twelve-year experience.

Defining juvenile idiopathic arthritis remission and optimum time for disease-modifying anti-rheumatic drug withdrawal: why we need a consensus.

Non-systemic juvenile idiopathic arthritis outcome after reaching clinical remission with anti-TNF-α therapy: a clinical practice observational study of patients who discontinued treatment.

Methotrexate withdrawal at 6 vs 12 months in juvenile idiopathic arthritis in remission: a randomized clinical trial.

P304

352-360

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3899/JRHEUM.161078

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Daniel B. Horton

Karen Onel

P577

2017-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28148696

http://www.w3.org/2001/XMLSchema#string

P932

5334187

http://www.w3.org/2001/XMLSchema#string